| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Institute of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands; and
Gesellschaft für Biotechnologische Forschung, Braunschweig, Germany
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Their conservation (and the consequent potential for the occurrence of molecular mimicry) made self-hsps into obvious candidate targets for pathologic T cell responses. This was seemingly demonstrated when the Ag of an arthritis-inducing T cell clone in the adjuvant arthritis (AA) model was found to be hsp60 of Mycobacterium tuberculosis (Mt) (1). However, the T cell epitope that was recognized turned out to be from a nonconserved part of the molecule having a molecular mimicry relationship with a cartilage associated non-hsp Ag but not with the corresponding mammalian hsp-sequence (2).
By now, ample evidence has been obtained for a protective role of immunization with hsps in experimental autoimmune diseases (reviewed in Ref. 3). For AA, it has been documented that preimmunization with microbial proteins belonging to different hsp families protect from subsequent arthritis induction: mycobacterial hsp70 (Ref. 4 , Prakken et al., submitted4) Mt hsp60 (2, 5, 6), and Mt hsp10 (7). In streptococcal cell wall-induced arthritis, immunization with Mt hsp60 was protective (8). Most importantly, protection with Mt hsp60 was also found in arthritis models induced with nonmicrobial agents like avridine (9), pristane (10, 11), and collagen (12). Other experimental autoimmune diseases were also inhibited by immunization with Mt hsp60: experimental autoimmune encephalomyelitis (13) and diabetes in nonobese diabetic mice (14). However, the mechanism of protection by hsp in autoimmune diseases remained unclear. Recently, we have related the protective effect of Mt hsp60 in experimental arthritis to self-hsp cross-reactive T cells as protection was transferable by these cells (15, 16).
Preimmunization with Mt hsp70 also protected in experimental arthritis, and this was likewise T cell mediated.4 In the present study, we analyzed the T cell response to Mt hsp70 to unravel the underlying protective mechanism. T cells specific for conserved Mt hsp70 peptides were tested for cross-reactivity to peptides representing the homologous rat hsp70 sequence. A conserved, cross-reactive T cell epitope of hsp70 was found. T cells raised against Mt hsp70 and this epitope induced strong expression of the anti-inflammatory cytokine IL-10, whereas T cells specific for other conserved protein immunogens did not. The cross-reactive epitope conferred a significant reduction of arthritis. Taken together the data presented here suggest that the induction of IL-10 producing T cells with a regulatory phenotype is a characteristic feature of immunization with hsps.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Male Lewis rats were obtained from the University of Limburg (Maastricht, The Netherlands). Rats were 6–8 wk old at the start of experiments.
Ags and adjuvants
Heat-killed Mt (strain H37Ra) was obtained from Difco (Detroit, MI). Purified recombinant Mt hsp70 was donated from Gesellschaft für Biotechnologische Forschung (Braunschweig, Germany). The following Ags were obtained from Brunswich/Sigma (Amsterdam, The Netherlands): recombinant G3PDH from Bacillus stearothermophilus (catalog no. G5892), rat GST (G8386), and superoxide dismutase from Escherichia coli (S5639).
Peptides were synthesized as described previously (17). They were prepared by automated simultaneous multiple peptide synthesis. The simultaneous multiple peptide synthesis set-up was developed using a standard autosampler (Gilson 221, Middleton, WI). Briefly, standard F-moc chemistry with in situ PyBop/N-methylmorpholine activation of the amino acids in a 5-fold molar excess with respect to 2 µmol/peptide PAL-PEG-PS resin (Perseptive Biosystems, Cambridge, MA) was employed. Peptides were obtained as C-terminal amides after cleavage with 90–95% TFA/scavenger mixtures. Peptide purity was determined by HPLC.
IFA (Difco) and dimethyl dioctadecyl ammonium bromide (DDA; Eastman Kodak, Rochester, NY) (18) were used as adjuvants. DDA was prepared as a 20 mg/ml suspension in PBS and sonicated/heated to produce a gel that was mixed 1:1 with Ag solution before immunization (16).
Immunizations
Rats were immunized with 50 µg of protein or peptide in 50 µl PBS/DDA in each hind footpad. Draining popliteal lymph nodes were removed 10 days later, disaggregated, washed three times, and used as source of primed lymph node cells (PLNC).
T cell proliferation assays
PLNC were cultured in triplicate as described previously (16). Briefly, 2 x 105 cells per well were cultured with the respective Ags for 96 h in 200-µl flat-bottom microtiter wells (Costar, Cambridge, MA). For the last 18 h, 1 µCi/well [3H]TdR (Amersham International, Bucks, U.K.) was added, and uptake was measured using a liquid scintillation beta counter.
Results are expressed as stimulation index calculated by dividing the mean cpm of triplicate cultures by the value for cells cultured without Ags.
T cell lines
T cell lines were generated as described previously (16). PLNC from rats immunized 10 days before with protein or peptide in DDA were stimulated in vitro at 5 x 106 cells/ml with 2% normal rat serum and 10 µg/ml of Ag in IMDM (Life Technologies, Gaithersburg, MD) supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, and 5 x 10-5 M 2-ME. Three days later, viable cells were isolated using a Ficoll gradient and were expanded in culture for 4 days in the presence of IMDM, 10% FCS (Seratech, Griesbach, Germany), and 10% T cell growth factor (Con A-activated rat spleen supernatant). In vitro restimulations were conducted in the presence of irradiated (3000 rad) thymocytes as APCs at a ratio of 100:1.
Induction and clinical assessment of experimental arthritis
AA was induced by a single intradermal injection of 0.5 mg Mt in 100 µl IFA in the base of the tail.
Rats were examined daily for clinical signs of arthritis in a blinded set-up. Severity of arthritis was assessed by scoring each paw from 0 to 4 based on the degree of swelling, erythema, and deformity of the joints (19). Thus, the maximum score per rat was 16.
Modulation of arthritis with hsp70 peptides by intranasal application
Over a period of 14 days before arthritis was induced, rats were treated with peptide (10 µl of 10 mg/ml peptide in PBS) or PBS only. Peptides were administered intranasally to lightly ether-anaesthetized rats on days -14, -11, -7, and -3 using a micropipette.
Cytokine detection by RT-PCR
At day 14 after immunization with 100 µg of the respective protein Ag in DDA, PLNC were isolated. Per sample, 4 x 105 PLNC were stimulated with 10 µg/ml of the corresponding protein for 18 h. RNA from these cells was used for the generation of cDNA by RT-PCR. PCR was performed with rat cytokine-specific primers (20): IL-2 primers, 5'-GCGCACCCACTTCAAGCCCT and 3'-CCACCACAGTTGCTGGCTCA; IL-4 primers, 5'-ATGCACCGAGATGTTTGTACC and 3'-TTTCAGTGTTCTGAGCGTGGA; IL-10 primers, 5'-TGCCTTCAGTCAAGTGAAGACT and 3'-AAACTCATTCATGGCCTTGTA. The signal obtained was measured after gel-electrophoresis with ethidium-bromide using an imaging densitometer (model GS-700; Bio-Rad, Hercules, CA) and standardized to a control PCR product of a housekeeping gene (G3PDH primers, 5'-ACCACAGTCCAT GCCATCAC and 3'-TCCACCACCCTGTTGCTGTA). Data are expressed as percentage of signal-strength for the cytokines in relation to the signal-strength of the housekeeping gene (=100%).
Statistical analysis
Differences between experimental groups were evaluated for the
maximum arthritis score observed for each rat by means of the
two-tailed Mann-Whitney U test. Differences were considered
significant at p 
0.05.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
For the definition of rat T cell epitopes in Mt hsp70, specific T
cell lines were generated by s.c. footpad immunization of Lewis rats
with recombinant mycobacterial hsp70 followed by in vitro restimulation
of draining PLNC. T cell epitopes of the generated T cell lines were
analyzed by peptide scans. Therefore, overlapping 15-mer peptides
covering the Mt hsp70 protein (see Fig. 1
for the sequence) were generated. The peptide representing the amino
acids 276–290 turned out to be a dominant nonconserved T cell epitope
for the Lewis rat (Fig. 2). Subsequently,
detailed attention was given to conserved regions as determined by the
sequence comparison between rat and bacterial hsp70 sequences. In Fig. 1, a comparison of Mt hsp70 with the highly stress-inducable rat
hsp70–1 (GenBank accession no. Q07439) is shown. Due to the high
sequence homologies that exist between mammalian members of the hsp70
family, only minor differences are seen when Mt hsp70 is compared with
other rat hsp70 molecules such as hsp70-2 (P14659), hsp70-3 (P55063),
GR75 (P48721), GR78 (P06761), and hsp70c (P08109) (data not shown). The
Mt hsp70 peptides representing conserved regions were tested as
potentially cross-reactive T cell epitopes for the Mt hsp70-specific
lines. Fig. 2 shows the data obtained for the conserved bacterial hsp70
sequences. Four peptides were found to contain T cell epitopes. These
epitopes were found to be present in peptides 111–125, 131–145,
397–411, and 490–504.
|
|
For the peptides representing the four major antigenic conserved
epitopes (peptides 111–125, 131–145, 397–411, and 490–504), T cell
lines were generated by immunization with the peptides and in vitro
peptide restimulations. The resulting T cell lines were analyzed for
cross-reactivity to the corresponding self-peptides (see Table I). Peptide p111 (positions 111–125 in
Mt hsp70) induced T cells that cross-reacted with the self-hsp epitope
(R111; corresponding to rat hsp70-1 aa 139–153). This T cell line
proliferated in response to both p111 and R111 to a similar level (Fig. 3A). Most importantly, it was
also possible to establish a T cell line by immunization with
self-peptide R111, which cross-reacted with the microbial peptide (see
Fig. 3B). T cells recognizing Mt hsp70 p111 were
RT1.Bl restricted (Fig. 4), as responses were inhibited
in the presence of Bl-specific Abs (OX6) and not
Dl-specific Abs (OX17). The response of T cells
to peptide R111 was similarly inhibited by
anti-Bl Abs.
|
|
|
The induction of cross-reactive responses nominated peptide p111 as a candidate T cell epitope responsible for the in vivo protective effect of Mt hsp70 preimmunization in experimental arthritis. Therefore, p111 in PBS together with the adjuvant DDA was s.c. injected in the footpad of Lewis rats followed by induction of AA 10 days later. Disease was first observed at day 10 in the p111 group and at day 8 in the PBS-only control group. Rats immunized with p111 showed a mean maximum disease score of 11.8, whereas the PBS control rats had a mean maximum score of 12.4. Thus, except for a weak delay in onset, no significant influence on disease course by parenteral p111 immunization could be observed.
Mt hsp70 and a conserved Mt hsp70 peptide induce IL-10 production in responding T cell populations
Subsequently, the cytokine profile of the T cells
responding to Mt hsp70 and epitopes thereof were analyzed. As control
proteins other conserved bacterial proteins with mammalian homologues
were chosen (G3PDH and superoxide dismutase) as well as a rat
self-protein (GST). Earlier, these proteins had been demonstrated to be
immunogenic but not to induce arthritis protection when used for
preimmunization.4 Cytokine mRNA levels detected
by RT-PCR in PLNC from rats immunized with the different Ags are shown
in Fig. 5. IL-2 was produced to a similar
degree in response to the Ags, correlating with similar levels of
proliferation found (not shown). Overall, very low expression of IL-4
was detectable. Analysis of IL-10 expression showed a divergent
pattern: high levels of IL-10 for Mt hsp70 and low levels or absence of
IL-10 mRNA for the other proteins (Fig. 5). The p111-specific T cell
line also induced IL-10 mRNA upon stimulation with the peptide and,
most importantly, also with the homologous self-peptide R111. Because
we were interested specifically in the cytokine levels induced by
antigenic stimulation of the T cells, we could not differentiate
between mRNA derived from residual APC and from the T cells. However,
in the absence of T cells or with T cells with an irrelevant
specificity, no induction of IL-10 mRNA was found.
|
As the IL-10 data suggested the possibility that Mt hsp70 and,
more particularly, its conserved p111 peptide generated regulatory T
cells that induce IL-10, we chose to optimize the induction of
regulatory T cell activity by administering the peptides intranasally.
Rats were given p111 in PBS intranasally four times over a period of 2
wk before arthritis was induced. Control groups of rats received PBS
alone or received a control peptide. P111-treated rats developed a
significantly reduced disease severity compared with control rats. In
the experiment shown (Fig. 6), the mean
maximum score for p111-treated rats was 4.4 (SEM, 0.9) and 8.6 (SEM,
1.5) for the PBS control group (p < 0.05;
Mann-Whitney U test). An immunogenic, nonconserved Mt hsp70
peptide (p276–290) did not suppress disease upon nasal administration
(mean maximum score 7.4 (SEM, 1.6)) as we found before with other
irrelevant peptides (21). In a second experiment, similar
results were obtained (data not shown).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
In the present study, the immune response to Mt hsp70 in the Lewis rat
was analyzed by screening T cell responses directed to a selected set
of hsp70 peptides. First of all, the T cell response was dominated by a
nonconserved T cell epitope involving a part of Mt hsp70 that has a low
degree of sequence homology with mammalian hsp70 (aa 276–290). Within
conserved parts of the molecule, multiple subdominant T cell epitopes
were found, even in areas of the molecule where five or more amino
acids of a potential MHC class II binding nonamer were identical with
self-hsp70 homologues (Table I
). However, it seems that T cell
recognition was mainly determined by nonconserved residues within such
conserved regions as most Mt hsp70 peptide-specific T cell lines failed
to recognize their mammalian homologue peptides as measured by
proliferation. Nonetheless, upon direct testing with the rat
homologues, one T cell epitope of Mt hsp70 (p111) was identified where
the specific T cells strongly cross-reacted with the self-peptide. In
the case of p111, eigth of nine amino acids from the
RT1.Bl-binding core epitope (as predicted by a
recently published RT1.Bl binding motif
(22)) were identical within the bacterial and rat
sequence. The facts that bacterial and self-peptide were recognized to
an identical extent (Fig. 3A) and in the context of the same
restriction element (RT1.Bl; Fig. 4) and that in
the reciprocal situation the T cell line generated against the
self-hsp70 peptide was also stimulated by the mycobacterial peptide
(Fig. 3B) indicate that the same T cells were indeed
triggered by both peptides. Thus, self-hsp70-reactive T cells can be
activated and expanded by immunization with Mt hsp70. As it has been
demonstrated that the synthesis of hsp, such as hsp60, is up-regulated
in arthritic joints (23) and as this also was shown more
recently for hsp70 (24), it is likely that MHC
presentation of self-hsp peptides is also enhanced in arthritic joints.
Therefore, migrating p111-specific T cells may encounter their Ag in
joints (or the respective draining lymph node) of arthritic rats where
they can recognize the rat homologue peptide on "stressed" APC or
MHC II-positive activated T cells (which also have an increased
expression of hsp70 (25)). After activation in the joint
(or local lymph node), the self-hsp-reactive T cells could exert their
predicted regulatory activity. This could well be reflected by the
course of arthritis seen in hsp70 peptide pretreated rats (Fig. 6),
where an initial joint inflammation started to develop (local
up-regulation of hsps) and then rapidly subsided (attraction and effect
of regulatory T cells).
Thus, up-regulated (stress response) self-hsp at sites of inflammation
could attract and/or activate self-hsp-reactive T cells. It is possible
that they display a regulatory phenotype influencing neighboring
harmful autoreactive T cells, either directly or indirectly through
cytokines. This would be in line with our findings because the T cells
generated by immunization with Mt hsp70 were strong inducers of IL-10
(Fig. 5), as was noted earlier for mycobacterial hsp70 in a
Listeria infection model in rats (26). Most
importantly, in our case, IL-10 was also induced by the self-reactive
p111-specific T cells (see Fig. 5) when stimulated with the
self-peptide. The most likely source of the IL-10 mRNA were the
Ag-specific stimulated T cells. Formally, the APC present for
Ag-specific stimulation could not be excluded as a source, but IL-10
mRNA was not induced by hsp70 Ags in the absence of T cells or with
irrelevant T cells.
The mechanism through which (self) hsp70-specific T cells developed an intrinsic capacity for IL-10 production may consist of a combination of several factors. First, presentation of self-hsp Ags is strongly associated/increased with cellular stress, a phenomenon which in itself promotes the production of IL-10, as has been shown in various cell types (27). Second, the generation of T cells in the dominant presence of IL-10 leads to T cells of a regulatory, IL-10-producing phenotype (28) or at least of an IL-10-producing Th2 phenotype (29). Third, for cross-reactive epitopes of bacterial hsps, it seems significant that they are taken up and presented in the gut mucosa where IL-10 (and TGF-ß) biased T cells are generated due to the local cytokine environment. (30). Therefore, stress-induced hsps may expand and propagate T cells that have already adopted a propensity to produce IL-10.
A study by Katsikis et al. (31) implicated a regulatory role for IL-10 in rheumatoid arthritis. Blocking of IL-10 in synovial membrane cultures from rheumatoid arthritis patients markedly increased the production of proinflammatory cytokines. Since then, a number of studies have demonstrated the beneficial effect of IL-10 in experimental collagen-induced arthritis (32, 33).
The actual regulatory mechanism of IL-10 could be inhibition of Ag
presentation capacities of local APCs. This regulatory mechanism has
been described for synovial macrophages (34).
Alternatively (or perhaps additionally), the working mechanism of IL-10
in the suppression of arthritis might be related either to inhibition
of IL-12 production by macrophages, thereby inhibiting a destructive
Th1 immune response (35, 36, 37), or to direct induction of
anergy in T cells present in the joint (38). Most
importantly, IL-10 production has recently been described
(28) as being the most prominent characteristic of a
subset of regulatory T cells (Tr1 cells) generated in the presence of
IL-10. In this study, similar to the data we have obtained for our
hsp70-specific T cells (Fig. 5), the T cells did not display a regular
Th2 phenotype as they did not produce IL-4.
IL-10 production as a mediator of arthritis suppression seems
compatible with the disease inhibitory effect of intranasal treatment
with p111 (Fig. 6) and the failed protection after parenteral
immunization with the peptide. The mucosal environment may well
influence developing immune responses by promoting the generation of
IL-10-producing T cells (28). In the case of the peptide
p111, this apparently leads to successful inhibition of disease (Fig. 6). It is possible that, in the case of the total hsp70 protein, the
presence of multiple conserved T cell epitopes obviates the need for
the more dominantly IL-10-promoting, intranasal routing to obtain an
arthritis-reducing effect. In contrast, the fast loading of MHC class
II molecules possible by the intranasal route as opposed to the slow
release of peptide from adjuvant will influence the momentarily
available dose and thus may influence T cell triggering. However,
subsequent experiments, in vitro and in vivo, to inhibit the actions of
IL10 using specific Abs will be required to clarify its role in the
disease suppressive mechanism exerted by the hsp cross-reactive T
cells.
Altogether, the present data have substantiated previous evidence that the arthritis suppressing quality of bacterial hsp immunization resides in conserved sequences of these molecules that have the potential of triggering self-hsp-reactive T cells. The regulatory phenotype (inherent or developing) of such T cells, characterized by IL-10 production, may be responsible for the mechanism through which such cells mediate bystander suppression targeted to sites of inflammation with up-regulated self-hsp. The triggering of such T cells in vivo through administration of conserved hsp peptides under IL-10-promoting conditions, such as nasal administration, may be a possible strategy for the development of novel immunotherapeutic interventions.
|
Acknowledgments |
|---|
|
Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Willem van Eden, Professor of Immunology, Utrecht University, Yalelaan 1, 3584 CL Utrecht, The Netherlands. E-mail address:
3 Abbreviations used in this paper: hsp, heat shock protein; Mt, Mycobacterium tuberculosis; AA, adjuvant arthritis; PLNC, primed lymphnode cells; DDA, dimethyl dioctadecyl ammonium bromide.
4 B.Y. Prakken, U. Wendling, R. van der Zee, V.P.M.G. Rutten, W. Kuis, W. van Eden. The induction of interleukin-10 and ihibition of heat-shock proteins and not of other evolutionary conserved immunodominant proteins. Submitted for publication.
Received for publication September 7, 1999. Accepted for publication December 27, 1999.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.This article has been cited by other articles:
|
|
 |
|
  F Hauet-Broere, L Wieten, T Guichelaar, S Berlo, R van der Zee, and W Van Eden Heat shock proteins induce T cell regulation of chronic inflammation Ann Rheum Dis, November 1, 2006; 65(suppl_3): iii65 - iii68. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Galazka, M. Stasiolek, A. Walczak, A. Jurewicz, A. Zylicz, C. F. Brosnan, C. S. Raine, and K. W. Selmaj Brain-Derived Heat Shock Protein 70-Peptide Complexes Induce NK Cell-Dependent Tolerance to Experimental Autoimmune Encephalomyelitis J. Immunol., February 1, 2006; 176(3): 1588 - 1599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen and R. W. Currie Small interfering RNA knocks down heat shock factor-1 (HSF-1) and exacerbates pro-inflammatory activation of NF-{kappa}B and AP-1 in vascular smooth muscle cells Cardiovasc Res, January 1, 2006; 69(1): 66 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Qazi, M. R. Qazi, E. Julian, M. Singh, M. Abedi-Valugerdi, and C. Fernandez Exposure to Mycobacteria Primes the Immune System for Evolutionarily Diverse Heat Shock Proteins Infect. Immun., November 1, 2005; 73(11): 7687 - 7696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, T. Whittall, E. McGowan, J. Younson, C. Kelly, L. A. Bergmeier, M. Singh, and T. Lehner Identification of Stimulating and Inhibitory Epitopes within the Heat Shock Protein 70 Molecule That Modulate Cytokine Production and Maturation of Dendritic Cells J. Immunol., March 15, 2005; 174(6): 3306 - 3316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Durai, H. R. Kim, and K. D. Moudgil The Regulatory C-Terminal Determinants within Mycobacterial Heat Shock Protein 65 Are Cryptic and Cross-Reactive with the Dominant Self Homologs: Implications for the Pathogenesis of Autoimmune Arthritis J. Immunol., July 1, 2004; 173(1): 181 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Hooper, J. J. Hooper, A. G. Pockley, A. Georgiades, T. Thulin, U. de Faire, and J. Frostegard Is Low-Heat Shock Protein 70 a Primary or a Secondary Event in the Development of Atherosclerosis? * Response: Is Low-Heat Shock Protein 70 a Primary or a Secondary Event in the Development of Atherosclerosis? Hypertension, April 1, 2004; 43(4): e18 - e19. [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Lillicrap, R. C. Duggleby, J. C. Goodall, and J. S. H. Gaston T cell recognition of a highly conserved epitope in heat shock protein 60: self-tolerance maintained by TCR distinguishing between asparagine and aspartic acid Int. Immunol., March 1, 2004; 16(3): 405 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Pockley, A. Georgiades, T. Thulin, U. de Faire, and J. Frostegard Serum Heat Shock Protein 70 Levels Predict the Development of Atherosclerosis in Subjects With Established Hypertension Hypertension, September 1, 2003; 42(3): 235 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Bodman-Smith, V. M. Corrigall, D. M. Kemeny, and G. S. Panayi BiP, a putative autoantigen in rheumatoid arthritis, stimulates IL-10-producing CD8-positive T cells from normal individuals Rheumatology, May 1, 2003; 42(5): 637 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J van Westerloo, N A Maris, M J Bruno, T van der Poll, L Bhagat, and A K Saluja Caerulein induced pancreatitis Gut, March 1, 2003; 52(3): 452 - 453. [Full Text] [PDF]
|
|
|
|
|
|
W van Eden, R van der Zee, P van Kooten, S E Berlo, P M Cobelens, A Kavelaars, C J Heijnen, B Prakken, S Roord, and S Albani Balancing the immune system: Th1 and Th2 Ann Rheum Dis, November 1, 2002; 61(90002): ii25 - 28. [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, C. G. Kelly, M. Singh, E. G. McGowan, A.-S. Carrara, L. A. Bergmeier, and T. Lehner Stimulation of Th1-Polarizing Cytokines, C-C Chemokines, Maturation of Dendritic Cells, and Adjuvant Function by the Peptide Binding Fragment of Heat Shock Protein 70 J. Immunol., September 1, 2002; 169(5): 2422 - 2429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Trinchieri Regulatory Role of T Cells Producing both Interferon {gamma} and Interleukin 10 in Persistent Infection J. Exp. Med., November 19, 2001; 194(10): F53 - F57. [Full Text] [PDF]
|
|
|
|
|
|
B. J. Prakken, U. Wendling, R. van der Zee, V. P. M. G. Rutten, W. Kuis, and W. van Eden Induction of IL-10 and Inhibition of Experimental Arthritis Are Specific Features of Microbial Heat Shock Proteins That Are Absent for Other Evolutionarily Conserved Immunodominant Proteins J. Immunol., October 15, 2001; 167(8): 4147 - 4153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Corrigall, M. D. Bodman-Smith, M. S. Fife, B. Canas, L. K. Myers, P. H. Wooley, C. Soh, N. A. Staines, D. J. C. Pappin, S. E. Berlo, et al. The Human Endoplasmic Reticulum Molecular Chaperone BiP Is an Autoantigen for Rheumatoid Arthritis and Prevents the Induction of Experimental Arthritis J. Immunol., February 1, 2001; 166(3): 1492 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. A. Paul, P. J. S. van Kooten, W. van Eden, and R. van der Zee Highly Autoproliferative T Cells Specific for 60-kDa Heat Shock Protein Produce IL-4/IL-10 and IFN-{gamma} and Are Protective in Adjuvant Arthritis J. Immunol., December 15, 2000; 165(12): 7270 - 7277. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
) and 5 µg/ml (
). Mt
hsp70 peptide p490 was used as a nonstimulatory control. The background
proliferation in the test was 332 cpm. SI, Stimulation index.
B, T cells specific for Rat p111 cross-react with the
corresponding Mt hsp70 p111 epitope. PLNC from a rat immunized with Rat
p111 cross-react with the Mt hsp70 p111 peptide. The background
proliferation was 6856 cpm.
,
n = 5) suppresses the development of subsequently
induced arthritis as compared with PBS-only controls (•,
n = 5).